OptimizeRx Corporation provided earnings guidance for the first quarter of 2024, for the quarter, the company expects revenue to increase over 40% year-over-year and come in between $18.5 million and $19.2 million with a GAAP net loss between $8.2 million - $7.0 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.29 USD | -1.74% | -6.69% | -21.10% |
Jun. 05 | Transcript : OptimizeRx Corporation - Shareholder/Analyst Call | |
May. 14 | Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.10% | 210M | |
+29.97% | 451B | |
+33.20% | 280B | |
+11.91% | 138B | |
+7.98% | 92.55B | |
+26.70% | 91.02B | |
+70.03% | 64.41B | |
+15.32% | 45.22B | |
+25.04% | 35.71B | |
-11.83% | 31.89B |
- Stock Market
- Equities
- OPRX Stock
- News OptimizeRx Corporation
- OptimizeRx Corporation Provides Earnings Guidance for the First Quarter of 2024